Page last updated: 2024-09-03

mosapride and glucagon

mosapride has been researched along with glucagon in 1 studies

Compound Research Comparison

Studies (mosapride)	Trials (mosapride)	Recent Studies (post-2010) (mosapride)	Studies (glucagon)	Trials (glucagon)	Recent Studies (post-2010) (glucagon)
286	90	142	26,039	1,498	3,054

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, K; Kamiyama, H; Masuda, K; Terauchi, Y; Togashi, Y	1

Trials

1 trial(s) available for mosapride and glucagon

Article	Year
Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men. Endocrine journal, 2013, Volume: 60, Issue:4 Topics: Adult; Benzamides; Blood Glucose; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Morpholines; Postprandial Period; Serotonin 5-HT4 Receptor Agonists; Up-Regulation	2013

Article

Year

Mosapride citrate, a 5-HT₄ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.

Endocrine journal, 2013, Volume: 60, Issue:4

Topics: Adult; Benzamides; Blood Glucose; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Morpholines; Postprandial Period; Serotonin 5-HT4 Receptor Agonists; Up-Regulation

2013